News

This week, we feature top articles from our sister publications on regulatory updates, clinical trial insights, and more.

Explore the latest advancements and expert insights from the Maui Derm NP+PA Fall 2025 conference in Nashville, Tennessee.

Rural patients face critical delays in dermatology care, highlighting the urgent need for expanded access and support for NPs and PAs in underserved areas.

Upadacitinib shows promising results in treating severe alopecia areata, achieving significant hair regrowth and setting new efficacy standards in therapy.

Bambusa Therapeutics reveals promising phase I trial results for BBT001, targeting atopic dermatitis with dual-action bispecific antibodies.

Virginia Sybert, MD, emphasizes the importance of judicious genetic testing in pediatric dermatology, advocating for collaboration to enhance patient care.

Derm Dispatch host Renata Block, DMSc, MMS, PA-C, and Buchi Neita, MCMSc, PA-C, discuss how to revolutionize dermatology with lifestyle medicine, enhancing skin health and overall well-being.

TRIV-509 is a dual KLK5/7 inhibitor that aims to address barrier dysfunction, inflammation, and itch in moderate to severe AD.

Explore how dermatology PAs and NPs are transforming patient care through technology, advocacy, and peer education with Andrew Baker, MBA, MPAS, PA-C.

This episode explores the controversy and lack of clear diagnostic criteria for TSW.

As we celebrate National APP Week, Melodie Young, MSN, A/GNP-C, highlights the evolution of dermatology NPs and PAs, emphasizing their vital role in patient care and ongoing professional development.

Jorge Garcia-Zuazaga, MD, MBA, FAAD, FACMS, shares how Apex Skin’s multi-site model advances clinical trial access, diversity, and execution.

Bristol Myers Squibb expands direct-to-patient pricing for deucravacitinib and apixaban, enhancing access and affordability for patients in need.

Explore cutting-edge insights from DERM 2025, focusing on innovative treatments and emerging research in dermatology for improved patient care.

Elena Hawryluk, MD, PhD, shares groundbreaking insights on pediatric dermatology and melanoma management at Maui Derm NP+PA, emphasizing innovative treatments.

Jerry Shapiro, MD, shares innovative strategies for diagnosing and managing scarring alopecia at Maui Derm NP+PA Fall 2025, enhancing patient outcomes.

By targeting IL-13, APG777 may allow for less frequent dosing compared to existing biologics.

Todd Schlesinger, MD, FAAD, FASMS, moderated an engaging discussion with colleagues to discuss complex vitiligo cases during a Dermatology Times Case-Based Roundtable event.

Discover educational insights on blistering diseases and innovative treatments like dupilumab at the Maui Derm NP+PA Fall 2025 conference.

Kara Mudd, PA-C, shares vital insights on atopic dermatitis, rosacea, and contact dermatitis from Maui Derm NP+PA Fall 2025, enhancing clinical practice.

Explore groundbreaking research and insights from the EADV Congress 2025, highlighting advancements in dermatology treatments and patient care.

Catch up on coverage from the fourth day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.

A poster at Maui Derm NP+PA Fall show trifarotene cream's promise in treating acne and post-inflammatory hyperpigmentation in diverse patients, enhancing skin health and appearance.

Walter Liszewski, MD, shares innovative and personalized treatment strategies for managing atopic and contact dermatitis at Maui Derm NP+PA Fall 2025.

Based on the diagnosis and treatment challenges of CSU, it’s crucial for allergists and dermatologists to work together toward an effective approach based on the latest evidence.

Discover key insights from Maui Derm NP+PA Fall 2025 on acne and rosacea treatments, featuring expert strategies from Hilary Baldwin, MD.

Discover the latest advancements in pediatric dermatology and atopic dermatitis treatments from Maui Derm NP+PA Fall 2025, featuring expert insights and emerging therapies.

Stephanie Simmerman, DNP, APRN-C, led discussions on psoriasis treatment innovations at Maui Derm NP+PA Fall 2025, highlighting NP and PA advancements.

Rebecca Smith, MD, recently led a Dermatology Times Case-Based Roundtable event on complex cases in atopic dermatitis.

Catch up on coverage from the third day of the Maui Derm NP+PA Fall 2025 conference held in Nashville, Tennessee.